PBH PBH プレステ―ジ・コンシュ―マ―・ヘルスケア

 PBHのチャート


 PBHの企業情報

symbol PBH
会社名 Prestige Consumer Healthcare Inc (PBH プレステ―ジ・コンシュ―マ―・ヘルスケア)
分野(sector)   
産業(industry)   
業種 小売_医薬品   医療関連(Health Care)
概要 事業概要 プレステージ・コンシューマー・ヘルスケア(Prestige Consumer Healthcare Inc.)(旧名:Prestige Brands Holdings Inc.)は店頭の医療製品のマーケティング・販売・流通に従事する。同社は北米店頭販売医療事業及び国際店頭販売医療事業の2つの主要事業を運営する。同社のOTC医療製品のポートフォリオには「DenTek」専門オーラルケア製品、「Monistat」女性健康製品、「Nix」シラミ治療製品、「Chloraseptic」咽頭治療製品、「Clear Eyes」アイケア製品、「Compound W」ワートトリートメント、「The Doctor''s NightGuard」歯科プロテクター、「Little Remedies」小児用市販薬、「Efferdent」義歯ケア製品、「Luden''s」咽頭ドロップ、「Dramamine」モーション病治療薬、「BC」と「Goody''s」鎮痛薬、「Beano」ガス防止薬、「Debrox」耳垢除去薬、「Gaviscon」制酸剤を含む。  プレスティ―ジ・ブランズ・ホ―ルディングスは、米国の持株会社。子会社を通じて、一般用医薬品、家庭用洗剤、パ―ソナルケア用品を販売。取り扱い製品は、口腔、眼、皮膚の治療薬のほか、咳、風邪、アレルギ―、鼻炎用薬品、および家庭用洗剤、スポンジ、たわし、清掃用布きんなど。  Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
本社所在地 914 524-6800
代表者氏名 Ronald M. Lombardi
代表者役職名 Chairman of the Board President Chief Executive Officer
電話番号 +1 914-524-6800
設立年月日 1996年
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 530人
url www.prestigebrands.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 329.06700
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 1549.29000
売上高 売上高(百万ドル) 990.71600
企業価値(EV) 企業価値(EV)(百万ドル) 3366.90600
当期純利益 当期純利益(百万ドル) 63.78700
決算概要 決算概要 BRIEF: For the nine months ended 31 December 2018 Prestige Consumer Healthcare Inc revenues decreased 6% to $734.8M. Net income before extraordinary items decreased 7% to $103.5M. Revenues reflect Household Cleaning segment decrease of 52% to $19.8M North Ameriican OTC Healthcare segment decrease of 2% to $430.7M International OTC healthcare segment decrease of 8% to $42.8M.

 PBHのテクニカル分析


 PBHのニュース

   Premium Brands Holdings Corporation Announces Second Quarter 2020 Conference Call  2020/07/24 07:00:00 Benzinga
VANCOUVER, BC, July 24, 2020 /CNW/ - Premium Brands Holdings Corporation (TSX:PBH), a leading producer, marketer and distributor of branded specialty food …
   Prestige Consumer Healthcare Inc. to Release Fiscal 2021 First Quarter Earnings Results  2020/07/13 20:45:00 GlobeNewswire
TARRYTOWN, N.Y., July 13, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 first…
   Prestige Brands (PBH) Up 3.5% Since Last Earnings Report: Can It Continue?  2020/06/06 15:31:37 Zacks Investment Research
Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Know This Before You Buy Premium Brands Holdings (TSX:PBH) Stock  2020/05/12 15:14:01 The Motley Fool Canada
Tempted to buy Premium Brands Holdings stock post Q1? Don’t buy it before you know this. The post Know This Before You Buy Premium Brands Holdings (TSX:PBH) Stock appeared first on The Motley Fool Canada .
   Premium Brands Holdings Corporation Announces Record Fourth Quarter and 2019 Sales and Adjusted EBITDA, a 10% Dividend Increase, Three New Business Investments and Guidance for 2020  2020/03/12 11:00:00 Yahoo Finance
Premium Brands Holdings Corporation Announces Record Fourth Quarter and 2019 Sales and Adjusted EBITDA, a 10% Dividend Increase, Three New Business Investments and Guidance for 2020

 関連キーワード  (小売_医薬品 米国株 PBH プレステ―ジ・コンシュ―マ―・ヘルスケア PBH )

 twitter  (公式ツイッターやCEOツイッターなど)